Mon. May 25th, 2026
Spread the love

 

Europe’s main stock markets mostly climbed Monday after strong gains for Chinese indices, as trading entered a traditionally weak month for Wall Street.

Hong Kong’s Hang Seng Index closed with a gain of 2.2 per cent, fuelled by the share price of Chinese e-commerce giant Alibaba soaring almost 20 per cent on bumper results, which included a surge in AI revenue.

Chinese equities also won support from official data showing that China’s factory output ticked up in August, analysts said.

The Purchasing Managers’ Index — a key measure of industrial output — was 49.4, up slightly from 49.3 in July.

However, it was also a fifth straight month of contraction, as only a figure above 50 indicates growth.

In Europe, the London and Frankfurt stock markets gained, approaching the halfway stage. Paris was flattened amid political turmoil in France over contested budget proposals.

Wall Street is closed Monday for Labor Day, while the dollar traded mixed against its main rivals.

“Stocks tend to underperform this month on both sides of the Atlantic,” noted Kathleen Brooks, research director at XTB trading group.

The tide already began to turn at the end of last week, with “an underwhelming set of results for (AI chip giant) Nvidia, along with a sharp selloff in stock markets in Europe and the US”, Brooks added.

 

READ ALSO: Alibaba Soars But Asia Markets Dip

Wall Street retreated from record highs Friday as a key US inflation reading accelerated, lowering the odds of sustained cuts to interest rates by the Federal Reserve in the coming months.

Also Friday, a US appeals court ruled that many of President Donald Trump’s tariffs, which have upended global trade, were illegal — but allowed them to remain in place for now, giving him time to take the fight to the Supreme Court.

– Key figures at around 1045 GMT –

London – FTSE 100: UP 0.1 per cent at 9,198.91 points

Paris – CAC 40: FLAT at 7,705.31

Frankfurt – DAX: UP 0.3 per cent at 23,975.42

Tokyo – Nikkei 225: DOWN 1.2 per cent at 42,188.79 (close)

Hong Kong – Hang Seng Index: UP 2.2 per cent at 25,671.78 (close)

Shanghai – Composite: UP 0.5 per cent at 3,875.53 (close)

New York – Dow: DOWN 0.2 per cent at 45,544.88 (close)

Euro/dollar: UP at $1.1722 from $1.1693 on Friday

Pound/dollar: UP at $1.3525 from $1.3507

Dollar/yen: UP at 147.11 from 147.01 yen

Euro/pound: UP at 86.68 pence from 86.56 pence

Brent North Sea Crude: UP 0.8 per cent at $68.04 per barrel

West Texas Intermediate: UP 0.9 per cent at $64.60 per barrel

 

 

AFP

 

The post European Stocks Climb After Robust Gains For Chinese Equities appeared first on Channels Television.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.